We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
- Authors
Sharafaddinzadeh, Naser; Moghtaderi, Ali; Kashipazha, Davood; Majdinasab, Nastaran; Shalbafan, Bita
- Abstract
Low-dose naltrexone (LDN) may promote psychological well-being as well as generalized health especially in autoimmune disorders. The objective of this study is to assess the effect of LDN on the Quality of Life (QoL) of patients with relapsing-remitting and secondary progressive multiple sclerosis (MS) using the scales and composite scores of the MSQoL-54 questionnaire.
- Publication
Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Vol 16, Issue 8, p964
- ISSN
1477-0970
- Publication type
Journal Article
- DOI
10.1177/1352458510366857